ClinicalTrials.gov
public full text
Public Domain
A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY3532226 in participants with type 2 diabetes mellitus (T2DM). Blood tests will be performed to check how much LY3532226 gets into the bloodstream and how long it takes the body to eliminate it. This is a 2-part study and will last approximately 16 weeks excluding screening period for each part, respectively.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3532226 in Healthy Participants#904852
- A Study of LY3410738 in Healthy Adult Participants#1137973
- A Study of LY3463251 in Healthy Participants#906560
- A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes#871541
- A Study of LY4355756 in Healthy Participants#831030
Record · ID 868322
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive